Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

Clinical trial NCT00979992 · COMPLETED

Trial details

NCT number: NCT00979992
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Clear Cell Adenocarcinoma Recurrent Ovarian Carcinoma

Start date: 2010-04-19
Primary completion: 2014-05-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.